Identification of novel rare sequence variation underlying heritable pulmonary arterial hypertension
暂无分享,去创建一个
W. Ouwehand | M. Humbert | W. Seeger | I. Prokopenko | N. Soranzo | P. Corris | M. Haimel | M. Bleda | D. Heel | H. Ghofrani | S. Gräf | R. Trembath | S. Holden | S. Ghio | L. Daugherty | N. Morrell | B. Girerd | D. Montani | M. Eyries | F. Soubrier | J. Wharton | M. Wilkins | H. Gall | L. Scelsi | D. Kiely | H. Olschewski | A. Noordegraaf | C. Rhodes | M. Newnham | E. Swietlik | Jennifer M. Martin | K. Yates | H. Bogaard | R. Condliffe | G. Kovacs | A. Olschewski | L. Howard | C. Danesino | Wei Li | R. Machado | S. Wort | D. Whitehorn | M. Aldred | L. Southgate | J. Gibbs | C. Hadinnapola | J. Hodgson | R. Salmon | M. Southwood | C. Treacy | O. Shamardina | C. Church | G. Coghlan | A. Houweling | S. Moledina | A. Peacock | J. Pepke-Żaba | D. Stein | J. Suntharalingam | M. Toshner | A. Lawrie | P. Upton | R. Ross | Katherine P. Yates | Bin Liu | Q. Waisfisz | Deborah Whitehorn | Jennifer M Martin | J. Pepke-Zaba
[1] K. Broman,et al. Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[3] T. Walz,et al. Structure of bone morphogenetic protein 9 procomplex , 2015, Proceedings of the National Academy of Sciences.
[4] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[5] Steve Lee,et al. Canvas: versatile and scalable detection of copy number variants , 2016, bioRxiv.
[6] J. Skepper,et al. Transcript Analysis Reveals a Specific HOX Signature Associated with Positional Identity of Human Endothelial Cells , 2014, PloS one.
[7] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[8] P. Thurner,et al. Sox17 is required for normal pulmonary vascular morphogenesis. , 2014, Developmental biology.
[9] D. Penny,et al. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report , 2016, BMC Pulmonary Medicine.
[10] M. Humbert,et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.
[11] M. Humbert,et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension , 2013, Nature Genetics.
[12] D. Stewart,et al. Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension , 2006, Circulation research.
[13] Hui Yang,et al. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR , 2015, Nature Protocols.
[14] M. Humbert,et al. Pulmonary arterial hypertension: epidemiology and registries. , 2013, Journal of the American College of Cardiology.
[15] R. Trembath,et al. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. , 2005, Circulation.
[16] Bong-Gyoon Han,et al. Structural basis of water-specific transport through the AQP1 water channel , 2001, Nature.
[17] R. Trembath,et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.
[18] Stephen Kaptoge,et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis , 2016, The Lancet. Respiratory medicine.
[19] Tom R. Gaunt,et al. The UK10K project identifies rare variants in health and disease , 2016 .
[20] L. David,et al. Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.
[21] A. Shillington,et al. Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.
[22] J. Cogan,et al. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele , 2009, Human mutation.
[23] Graham M Lord,et al. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension , 2011, Human mutation.
[24] M. Humbert,et al. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects , 2015, Human mutation.
[25] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[26] J. R. MacDonald,et al. A copy number variation map of the human genome , 2015, Nature Reviews Genetics.
[27] Matthias Wilmanns,et al. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. , 2003, Genes & development.
[28] L. David,et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.
[29] W. Chung,et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. , 2014, Chest.
[30] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[31] Xiaoyu Chen,et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..
[32] M. Saier,et al. Bioinformatic Characterization of P-Type ATPases Encoded Within the Fully Sequenced Genomes of 26 Eukaryotes , 2009, Journal of Membrane Biology.
[33] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[34] C. R. Burke,et al. Characterization of the P5 subfamily of P-type transport ATPases in mice. , 2004, Biochemical and biophysical research communications.
[35] Prasanna R Kolatkar,et al. The structure of Sox17 bound to DNA reveals a conserved bending topology but selective protein interaction platforms. , 2009, Journal of molecular biology.
[36] R. Matsuoka,et al. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension , 2009, Journal of Medical Genetics.
[37] V. S. Zhdanov,et al. [Pathology of primary pulmonary hypertension]. , 1993, Arkhiv patologii.
[38] R. Hiramatsu,et al. Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice , 2006, Journal of Cell Science.
[39] S. Batzoglou,et al. Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.
[40] Bruce S Weir,et al. Model-free Estimation of Recent Genetic Relatedness. , 2016, American journal of human genetics.
[41] A. Zorn,et al. Sox17 and β-catenin cooperate to regulate the transcription of endodermal genes , 2004 .
[42] D. Geerts,et al. ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers. , 2016, American journal of cancer research.
[43] C. Toyoshima,et al. Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state , 2013, Nature.
[44] Wagenvoort Ca. The pathology of primary pulmonary hypertension. , 1970 .
[45] W. Chung,et al. Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension , 2012, Circulation. Cardiovascular genetics.
[46] W. Chung,et al. A novel channelopathy in pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[47] Fengyuan Hu,et al. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension , 2017, Circulation.
[48] M. Humbert,et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.
[49] Xiaowei Zhan,et al. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data , 2016, Bioinform..
[50] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[51] S. Gräf,et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension , 2015, Nature Medicine.
[52] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] E. Bongers,et al. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension , 2013, Journal of Medical Genetics.
[54] Jiaxuan Chen,et al. Conversion of Sox17 into a Pluripotency Reprogramming Factor by Reengineering Its Association with Oct4 on DNA , 2011, Stem cells.
[55] N. Morrell,et al. Regulation of Bone Morphogenetic Protein 9 (BMP9) by Redox-dependent Proteolysis* , 2014, The Journal of Biological Chemistry.
[56] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[57] M. Gassmann,et al. Aquaporin 1 controls the functional phenotype of pulmonary smooth muscle cells in hypoxia-induced pulmonary hypertension , 2017, Basic Research in Cardiology.
[58] Marios C. Papadopoulos,et al. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption , 2005, Nature.
[59] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[60] Christian X. Weichenberger,et al. FamAgg: an R package to evaluate familial aggregation of traits in large pedigrees , 2016, Bioinform..
[61] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[62] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[63] M. Corada,et al. Sox17 is indispensable for acquisition and maintenance of arterial identity , 2013, Nature Communications.
[64] Timothy A Thornton,et al. Robust Inference of Population Structure for Ancestry Prediction and Correction of Stratification in the Presence of Relatedness , 2015, Genetic epidemiology.
[65] A. Zorn,et al. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. , 2004, Development.
[66] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.